Pain Management Devices Market Set for 8.6% CAGR Growth

According to a report the global pain management devices market is expected to reach $3.3 billion by 2026, growing at a compound annual rate of 8.6%. These devices help patients manage both chronic and acute pain associated with conditions like cancer, neurological disorders, and musculoskeletal issues.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91418163

There are several key factors driving growth in this market:
– An aging population with a growing need for long-term pain relief
– Increasing preference for devices over pain medications due to side effects
– High efficacy of pain management devices in treating chronic pain
– Continued innovation leading to new types of devices

Neurostimulation devices that work by disrupting pain signals make up the largest product segment currently. These implantable or external devices have shown good results for neuropathic pain in particular. Other segments include ablation devices that destroy pain nerves and infusion pumps that deliver pain medication directly.   

North America is the dominant regional market driven by favorable regulations and reimbursement policies as well as an abundance of industry players based in the U.S. However, growth opportunities exist around the world as healthcare infrastructure modernizes.  

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=91418163 

Some of the prominent players operating in the pain management devices market are Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players. With an expanding patient population and ongoing product innovation, the outlook remains positive for the pain management device industry over the long term. Companies that gain a competitive edge stand to benefit the most from rising global demand.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ’GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : PRSync – http://prsync.com/marketsandmarkets—hc/pain-management-devices-market-set-for–cagr-growth-4017238/